Last reviewed · How we verify

NCT05404412

The Impact of Contrast Media Used in Epidural Steroid Injections on Thyroid Function Tests

Completed Last updated 20 April 2023
What this trial tests

trial testing Epidural Steroid Injection in Lumbar Radiculopathy in 124 participants. Completed in 3 February 2023.

Timeline
1 June 2022
Primary endpoint
15 July 2022
3 February 2023

Quick facts

Lead sponsorMarmara University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment124
Start date1 June 2022
Primary completion15 July 2022
Estimated completion3 February 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Marmara University

Who can join

Adults 18 to 65, any sex, with Lumbar Radiculopathy or Lumbar Spinal Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is aim to disclose the effect of contrast media, which used in epidural steroid injections, on the parameters of thyroid function tests (TFTs). The patients who underwent an epidural steroid injection were included. The investigators hypothesized that contrast media owing to contain iodine may impair the values of TFTs.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Impact of Iodinated Contrast Media Used in Epidural Steroid Injections on Thyroid Function Tests.
    Isik R, Kokar S, Olgun Y, Sencan S, et al · · 2024 · PMID 39497879 · DOI 10.7759/cureus.70888

Verify or expand the search:

Other trials of Epidural Steroid Injection

Trials testing the same drug.

Other recruiting trials for Lumbar Radiculopathy

Currently open trials in the same condition.

Other Marmara University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05404412.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing